Canada Markets open in 5 hrs 20 mins

STAAR Surgical Company (STAA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
111.58+9.55 (+9.36%)
At close: 04:00PM EDT
110.29 -1.29 (-1.16%)
After hours: 04:35PM EDT
Full screen
Loading interactive chart...
  • Motley Fool

    Why STAAR Surgical Stock Is Triumphant Today

    STAAR Surgical (NASDAQ: STAA) stock was up by 16% as of 3:36 p.m. ET on Thursday after it smashed the market's expectations for its second-quarter earnings, reporting net sales of $81.1 million and $0.26 in net income per diluted share. The strong sales in China and India indicate that STAAR's ongoing push into major international vision correction markets is going swimmingly. Right now, its market share in China is estimated to be above 20%, which bodes well for its future performance there.

  • Zacks

    Staar Surgical (STAA) Q2 Earnings and Revenues Beat Estimates

    Staar Surgical (STAA) delivered earnings and revenue surprises of 68% and 1.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems

    LAKE FOREST, Calif., August 10, 2022--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced its partnership with singer, songwriter, and actor, Joe Jonas, to raise awareness of its EVO Visian® Implantable Collamer® Lenses (EVO). EVO is an FDA-approved vision correction lens designed for the correction/reduction of myopia and astigmatism. Joe Jonas had myopia since childhood, which is